| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Sep 09, 2021 | Sep 14, 2021 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $546.78 | $3M | -20.57% |
| Aug 03, 2021 | Aug 05, 2021 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $515.87 | $1M | -9.21% |
| Jul 06, 2021 | Jul 08, 2021 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $430.14 | $1M | -9.04% |
| Jun 03, 2021 | Jun 07, 2021 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $375 | $896,625 | -6.77% |
| Mar 10, 2021 | Mar 12, 2021 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $362.92 | $2M | -13.62% |
| Sep 15, 2020 | Sep 16, 2020 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $397.35 | $2M | -12.88% |
| Sep 09, 2020 | Sep 11, 2020 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $398.3 | $2M | -10.09% |
| Jun 15, 2020 | Jun 17, 2020 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $366.47 | $2M | -12.57% |
| Apr 15, 2020 | Apr 17, 2020 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $283.39 | $2M | -11.42% |
| Mar 11, 2020 | Mar 14, 2020 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $264.82 | $2M | -12.23% |
| Sep 18, 2019 | Sep 19, 2019 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $151.46 | $361,384 | -3.96% |
| Sep 09, 2019 | Sep 12, 2019 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $151.56 | $1M | -13.12% |
| Sep 03, 2019 | Sep 05, 2019 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $170 | $6,290 | -0.05% |
| Jun 05, 2019 | Jun 06, 2019 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $125 | $978,125 | -10.13% |
| Mar 12, 2019 | Mar 13, 2019 | Balo Andrew K * | Sell | Dexcom Inc | DXCM | $142.79 | $2M | -12.39% |
| Dec 14, 2018 | Dec 18, 2018 | Balo Andrew K EVP Reg. Strategy Clinical | Sell | Dexcom Inc | DXCM | $121.23 | $606,167 | -6.40% |
| Nov 14, 2018 | Nov 16, 2018 | Balo Andrew K EVP Reg. Strategy Clinical | Sell | Dexcom Inc | DXCM | $143.13 | $715,664 | -6.02% |
| Oct 12, 2018 | Oct 16, 2018 | Balo Andrew K EVP Reg. Strategy Clinical | Sell | Dexcom Inc | DXCM | $124.79 | $623,934 | -5.68% |
| Sep 14, 2018 | Sep 18, 2018 | Balo Andrew K EVP Reg. Strategy Clinical | Sell | Dexcom Inc | DXCM | $145.17 | $725,851 | -5.37% |
| Sep 10, 2018 | Sep 13, 2018 | Balo Andrew K EVP Reg. Strategy Clinical | Sell | Dexcom Inc | DXCM | $143.76 | $803,160 | -5.66% |
| Aug 14, 2018 | Aug 16, 2018 | Balo Andrew K EVP Reg. Strategy Clinical | Sell | Dexcom Inc | DXCM | $124.25 | $621,253 | -4.83% |
| Jul 16, 2018 | Jul 18, 2018 | Balo Andrew K EVP Reg. Strategy Clinical | Sell | Dexcom Inc | DXCM | $99.56 | $497,816 | -4.61% |
| Dec 11, 2017 | Dec 13, 2017 | Balo Andrew K EVP Reg. Strategy Clinical | Sell | Dexcom Inc | DXCM | $61.23 | $198,691 | -3.92% |
| Nov 29, 2017 | Dec 01, 2017 | Balo Andrew K EVP Reg. Strategy Clinical | Sell | Dexcom Inc | DXCM | $60 | $389,400 | -7.27% |
| Sep 11, 2017 | Sep 13, 2017 | Balo Andrew K EVP Reg. Strategy Clinical | Sell | Dexcom Inc | DXCM | $72.27 | $234,441 | -3.51% |
| Aug 10, 2017 | Aug 11, 2017 | Balo Andrew K EVP Reg. Strategy Clinical | Sell | Dexcom Inc | DXCM | $71.18 | $230,921 | -3.14% |
| Jul 10, 2017 | Jul 12, 2017 | Balo Andrew K EVP Reg. Strategy Clinical | Sell | Dexcom Inc | DXCM | $71.55 | $228,972 | -3.01% |
| Jun 12, 2017 | Jun 13, 2017 | Balo Andrew K EVP Clinical Regulatory | Sell | Dexcom Inc | DXCM | $69.06 | $220,989 | -2.92% |
| May 10, 2017 | May 12, 2017 | Balo Andrew K EVP Clinical Regulatory | Sell | Dexcom Inc | DXCM | $71.93 | $230,176 | -2.84% |
| Apr 10, 2017 | Apr 12, 2017 | Balo Andrew K EVP Clinical Regulatory | Sell | Dexcom Inc | DXCM | $78.19 | $250,208 | -2.76% |